FENTON BRIAN enters TRANSLATE BIO, INC. with 125.50K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 6/27/2018ACC: 0000899243-18-018429
Officer· Chief Business Officer
Since Mar 2019
125.50K
Baseline shares
100% direct
125.50K
Direct ownership
1 position
167.59K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned125.50K
Total
125.50K direct125.50K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 125.50K | Direct |
| Total | 125.50K | 125.50K direct |
Derivative Holdings2
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
98.76K
Shares owned
N/A
Exercise price
8.34
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
68.83K
Shares owned
N/A
Exercise price
7.39
Expiration
—
Exercise window
—
Total
Underlying
167.59K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock | 8.34 | — | — | 98.76K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 7.39 | — | — | 68.83K | N/A |
| Total | 167.59K | 0.00 | ||||